Sign in
Home
About Us
Contact Us
Privacy Policy
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Australian Biotech Company News
Home
About Us
Contact Us
Privacy Policy
Home
Tags
Immuno-oncology
Tag: Immuno-oncology
Biotechnology
NK Cell Developer Cytovia Pursues SPAC Merger, Bucking the Bear Market
BioChannel
-
May 5, 2022
Biotechnology
StockWatch: Checkmate Shares Quadruple on Regeneron Buyout
BioChannel
-
April 22, 2022
Biotechnology
Vitamin E Can Enliven Dendritic Cells, Enhance Cancer Immunotherapy
BioChannel
-
April 15, 2022
Biotechnology
Tips to Design Successful Immuno-Oncology Efficacy Studies to Push Drug Discovery...
BioChannel
-
April 9, 2020
Biotechnology
Brain Cancer CAR T Cell Therapy Guided by Scorpion Toxin Starts...
BioChannel
-
March 6, 2020
Biotechnology
GSK, Immatics Ink Up-to-$1B Cancer Immunotherapy Collaboration
BioChannel
-
February 20, 2020
Biotechnology
Engineered Probiotic Bacteria Deliver Anticancer Nanobodies to Regress Tumors in Mice
BioChannel
-
February 13, 2020
Biotechnology
OncoCyte Launches NSCLC Stratification Test, Looks beyond Lung Cancer
BioChannel
-
January 24, 2020
Biotechnology
“Skeleton Key” T-Cell Receptor Works across Multiple Cancer Types
BioChannel
-
January 23, 2020
Biotechnology
Astellas Acquires Xyphos for Up to $665M, Boosting Cancer Immunotherapy Pipeline
BioChannel
-
December 27, 2019
1
2
Page 1 of 2
Recent posts
NADIM II trial provides further support for neoadjuvant chemoimmunotherapy for patients with resectable non-small...
BioChannel
-
August 8, 2022
Genmab and BioNTech expand collaboration to develop and commercialize immunotherapy candidates
BioChannel
-
August 8, 2022
Apriori Bio’s AI Platform Provides Variant-Proof Protection from Viral Threats
BioChannel
-
August 8, 2022
Random article
NADIM II trial provides further support for neoadjuvant chemoimmunotherapy for patients...
Genmab and BioNTech expand collaboration to develop and commercialize immunotherapy candidates
Apriori Bio’s AI Platform Provides Variant-Proof Protection from Viral Threats
Lithuanian biotech group develops closer ties with Korea’s biotech industry –...
